Sinclair Research Launches Virtual Audit Solution to Provide Customers With a Customizable Alternative to In-Person Facility Audits and Tours

AUXVASSE, Mo.–(BUSINESS WIRE)–Feb 4, 2021–
Sinclair Research, a leading provider of nonclinical contract research services, today announced its new virtual audit capabilities, allowing clients worldwide to conduct comprehensive vendor qualifications, facility audits and tours remotely.
“The COVID-19 pandemic emphasized the importance of agility and flexibility when conducting nonclinical research and inspired us to rethink how we work and make it easier on our customers,” says Sinclair Research’s Vice President of Commercial Operations Andy Brown. “The impact of travel restrictions and public health mandates prompted us to implement a reliable alternative to conducting in-person facility qualifications, audits and tours.”
Sinclair Research’s virtual audits offer clients and consultants an innovative, customizable experience to meet the individual needs of their research program. Sinclair’s secure virtual platform is designed to quickly and effectively share information clients need to conduct a comprehensive virtual audit or facility tour.
“We have received positive feedback on our new virtual audit capabilities from several clients,” says Tom O’Toole, Sinclair Research’s Senior Director of Compliance. “From the initial planning meeting to the completion of document review and live-streamed facility tour, each client can customize their virtual audit for a thorough experience that meets the expectations of what they would be able to accomplish if they were physically on site.”
Sinclair Research’s fully customizable virtual audit solutions include:

  • Qualification Audits: Sinclair Research’s virtual qualification audit includes pre-audit meetings, detailed scope, fully defined agenda, full access to requested documents, and interviews.
  • Live Video Facility Tours: Sinclair’s virtual audits include an optional facility tour, offering customers the opportunity to observe areas of interest in real-time. Each virtual tour is tailored to meet customer-specific needs and focused on exactly what areas and features of the facility customers want to see.
  • Study-related Monitoring: Sinclair offers a flexible virtual experience for study-related monitoring. The team coordinates directly with customers to ensure an experience that meets client study requirements, all on a secure virtual platform designed to safeguard data.
  • Budget Savings: Virtual facility qualification offers greater flexibility, eliminates associated travel costs, and mitigates the potential health impacts to your team and our staff.

Download the PDF resource to learn more: https://sinclairresearch.com/virtual-audits
About Sinclair Research
Sinclair Research, a mid-sized nonclinical contract research organization (CRO), offers animal efficacy models, pharmacokinetics/pharmacodynamics evaluation, IND-enabling toxicology and safety pharmacology research capabilities to support biopharmaceutical, animal health and medical device development programs. Sinclair is experienced in a wide range of therapeutic modalities, routes of administration and research models. With more than 50 years of experience, Sinclair is the undisputed expert in miniature swine studies and has emerged as a leader in diabetes, dermal, otic and animal health research services with streamlined quality systems supporting both VICH and GLP-compliant studies and SEND reporting with no backlog.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210204005698/en/
CONTACT: George Kerrick
(573) 387-4400
communications@sinclairresearch.com
KEYWORD: UNITED STATES NORTH AMERICA MISSOURI
INDUSTRY KEYWORD: TECHNOLOGY MEDICAL DEVICES GENERAL HEALTH HOSPITALS SCIENCE VETERINARY CLINICAL TRIALS CARDIOLOGY BIOTECHNOLOGY HEALTH OTHER SCIENCE RESEARCH OTHER TECHNOLOGY AUDIO/VIDEO OTHER HEALTH PHARMACEUTICAL DATA MANAGEMENT
SOURCE: Sinclair Research
Copyright Business Wire 2021.
PUB: 02/04/2021 09:00 AM/DISC: 02/04/2021 09:01 AM
http://www.businesswire.com/news/home/20210204005698/en